Showing results (41-50 of 81) with videos related to
Sort By:
Pageof 9
Frontiers in Cardiovascular Medicine|June 23, 2023
A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysisDaniela P Mendes-de-Almeida, Fernanda S G Kehdy, Remy Martins-Gonçalves, et al.The Lancet. Infectious Diseases|March 5, 2021
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trialNathalie De Castro, Olivier Marcy, Corine Chazallon, et al.Retrovirology|December 14, 2018
Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infectionHury Hellen Souza de Paula, Ana Cristina Garcia Ferreira, Diogo Gama Caetano, et al.Tropical Medicine and Infectious Disease|June 27, 2023
Invasive Pneumococcal Disease in People Living with HIV: A Retrospective Case-Control Study in BrazilRoxana Flores Mamani, Tiago de Assunção López, Waldir Madany Jalo, et al.The Lancet. HIV|October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialRobert Gross, Lu Zheng, Alberto La Rosa, et al.American Journal of Epidemiology|November 1, 2019
The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin AmericaPablo F Belaunzarán-Zamudio, Yanink N Caro-Vega, Bryan E Shepherd, et al.Journal of the International AIDS Society|March 7, 2022
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas studyEmilia M Jalil, Thiago S Torres, Paula M Luz, et al.BMC Infectious Diseases|May 13, 2025
Tuberculosis disease characteristics associated with mortality, severe morbidity and unsuccessful treatment in people living with HIV treated for tuberculosis - a secondary analysis of the ANRS 12300 Reflate TB2 trialRobert Akpata, Jean-Baptiste Ntakpe, Eugène Messou, et al.AIDS (London, England)|June 9, 2026
Characterization of HIV acquisitions during a large oral PrEP implementation study: insights from the ImPrEP studyBrenda Hoagland, Thiago Silva Torres, Carolina Coutinho, et al.Vaccine|August 6, 2024
Anti-PF4 positivity and platelet activation after Ad26.COV2·S vaccination in BrazilJoanna Bokel, Remy Martins-Gonçalves, Eduarda Grinsztejn, et al.Pageof 9